tradingkey.logo

Clearpoint Neuro Inc <CLPT.OQ> expected to post a loss of 16 cents a share - Earnings Preview

ReutersMay 9, 2025 9:31 PM
  • Clearpoint Neuro Inc CLPT.OQ CLPT.O is expected to show a rise in quarterly revenue when it reports results on May 13 for the period ending March 31 2025

  • The Solana Beach California-based company is expected to report a 7.3% increase in revenue to $8.2 million from $7.64 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

  • ​LSEG's mean analyst estimate for Clearpoint Neuro Inc is for a loss of 16 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Clearpoint Neuro Inc is $28.00​, above​ its last closing price of $14.25. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.19

-0.16

-0.20

Missed

-22.5

Sep. 30 2024

-0.19

-0.17

-0.18

Missed

-3.8

Jun. 30 2024

-0.19

-0.20

-0.16

Beat

18.6​

Mar. 31 2024

-0.18

-0.19

-0.16

Beat

15.8

​​Dec. 31 2023

-0.18

-0.20

-0.19

Beat

6.6

Sep. 30 2023

-0.25

-0.25

-0.20

Beat

20​

Jun. 30 2023

-0.19

-0.19

-0.29

Missed

-52.6

Mar. 31 2023

-0.18

-0.18

-0.23

Missed

-24.3

This summary was machine generated May 9 at 21:31 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI